Cargando…

Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice

BACKGROUND: Cancer cachexia is a metabolic wasting syndrome that is strongly associated with a poor prognosis. The initiating factors causing fat and muscle loss are largely unknown. Previously, we found that leukaemia inhibitory factor (LIF) secreted by C26 colon carcinoma cells was responsible for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandarian, Susan C., Nosacka, Rachel L., Delitto, Andrea E., Judge, Andrew R., Judge, Sarah M., Ganey, John D., Moreira, Jesse D., Jackman, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240747/ https://www.ncbi.nlm.nih.gov/pubmed/30270531 http://dx.doi.org/10.1002/jcsm.12346

Ejemplares similares

Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
por: Nosacka, Rachel L., et al.
Publicado: (2020)

Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia
por: Judge, Sarah M, et al.
Publicado: (2014)

Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia
por: Delitto, Daniel, et al.
Publicado: (2016)

Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine
por: Gerber, Michael H., et al.
Publicado: (2018)

Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
por: Matsumoto*, T, et al.
Publicado: (1999)

Humoral mediation for cachexia in tumour-bearing rats.
por: Tessitore, L., et al.
Publicado: (1993)

FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
por: Neyroud, Daria, et al.
Publicado: (2021)

Theophylline is able to partially revert cachexia in tumour-bearing rats
por: Olivan, Mireia, et al.
Publicado: (2012)

Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival
por: Judge, Sarah M, et al.
Publicado: (2019)

IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy
por: Callaway, Chandler S., et al.
Publicado: (2019)

Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats
por: Oliveira, André G., et al.
Publicado: (2016)

Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice
por: Bing, C, et al.
Publicado: (2006)

Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour‐bearing mice
por: Brown, Jacob L., et al.
Publicado: (2017)

Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia
por: Underwood, Patrick W., et al.
Publicado: (2020)

Thyroid Tumours,Lymphomas, Granulocytic Leukaemia
por: Duthie, M. B., et al.
Publicado: (1973)

Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture
por: Jackman, Robert W., et al.
Publicado: (2017)

Modeling human cancer cachexia in colon 26 tumor-bearing adult mice
por: Talbert, Erin E., et al.
Publicado: (2014)

Corrigendum: Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture
por: Jackman, Robert W., et al.
Publicado: (2019)

Case of Lymphatic Leukæmia, with Tumour in the Mediastinum
por: Gowans, James
Publicado: (1876)

Tumour-associated hypoglycaemia in a murine cachexia model.
por: McDevitt, T. M., et al.
Publicado: (1992)

Proceedings: Tumour inhibitory triazenes.
por: Wilman, D. E.
Publicado: (1975)

Presence and significance of tumour cells in the spleen of tumour-bearing hamsters.
por: Zuinghedau, J., et al.
Publicado: (1979)

Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
por: Mahony, S. M., et al.
Publicado: (1988)

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
por: Wu, Qi, et al.
Publicado: (2018)

Effect of Sipjeondaebo-Tang on Cancer-Induced Anorexia and Cachexia in CT-26 Tumor-Bearing Mice
por: Choi, Youn Kyung, et al.
Publicado: (2014)

C26 Cancer-Induced Muscle Wasting Is IKKβ-Dependent and NF-kappaB-Independent
por: Cornwell, Evangeline W., et al.
Publicado: (2014)

Cancer cachexia impairs neural respiratory drive in hypoxia but not hypercapnia
por: Fields, Daryl P., et al.
Publicado: (2018)

On the Failure of Tumour Homogenate Injections to Simulate Quantitatively the Changes in Catalase Activity in the Tumour-bearing host
por: Adams, D. H.
Publicado: (1961)

Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors
por: Villars, Fabienne O., et al.
Publicado: (2017)

The Significance of Splenomegaly in Tumour-Bearing Mice
por: Woodruff, M. F. A., et al.
Publicado: (1962)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Tumour‑derived exosomes and their emerging roles in leukaemia (Review)
por: Chen, Lei, et al.
Publicado: (2023)

Effect of insulin on weight loss and tumour growth in a cachexia model.
por: Beck, S. A., et al.
Publicado: (1989)

Characterization of cachexia in the human fibrosarcoma HT‐1080 mouse tumour model
por: Bernardo, Barbara, et al.
Publicado: (2020)

Expression of p53 in urothelial cell cultures from tumour-bearing and tumour-free patients.
por: Harney, J., et al.
Publicado: (1995)

Characterization of Mice Bearing Subclones of Colon 26 Adenocarcinoma Disqualifies Interleukin‐6 as the Sole Inducer of Cachexia
por: Soda, Kuniyasu, et al.
Publicado: (1994)

Anorexia‐cachexia syndrome in hepatoma tumour‐bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC‐1/GDF15
por: Borner, Tito, et al.
Publicado: (2016)

Anti-angiogenic activity of ShengMaBieJia decoction in vitro and in acute myeloid leukaemia tumour-bearing mouse models
por: Wang, Mengya, et al.
Publicado: (2020)

Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
por: Kearney, R., et al.
Publicado: (1980)

Aging Aggravates Cachexia in Tumor-Bearing Mice
por: Geppert, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iqia8utngqneub5tkdehajound